Firms

Health Catalyst Capital

New York, New York, United States

Health Catalyst Capital (HCC) is a New York private-equity manager focused on healthcare information technology and healthcare services. Its legal adviser is Health Catalyst Capital Management LLC, SEC CRD282602/file801-119194; it is distinct from the publicly traded Health Catalyst healthcare-software company. Founded in2015, HCC invests in growth businesses through primary capital and secondary share purchases, supporting virtual care, process automation, data and AI, value-based care and patient engagement. Its official portfolio includes neuroscience and behavioral-health technology such as Click Therapeutics and Holmusk, and healthcare AI/data platforms including Pager Health, Clearsense, Quarvis, Datavant and Insightin. Portfolio listing alone does not establish a financing stage, ticket or currently held ownership. Its current directory publishes six core professionals and seventeen external advisers, whose external career histories are not asserted as current full-time HCC employment. April28,2026 FormADV corroborates the legal manager and six exact private vehicles, including flagship, annex, continuation and CFG-Elevance One partnerships. Regulatory assets, gross fund assets, targets, secondary purchase values and conditional subscriptions are not presented as completed fundraising cash. Direct SEC FormD filings establish a fully sold USD4M Annex FundII offering and USD103,763,908 CFG-Elevance One offering; the other vehicle sizes remain qualified or undisclosed. Its actual Click2021SeriesB participation is recorded separately with no assumed individual ticket or fund allocation. Native authentic logo and named portraits are retained; CFO Paula Semelmacher’s website silhouette is rejected, with no fabricated replacement.

Founded: 2015
Type: Venture capital

Funds6

CFG - ELEVANCE ONE, L.P.2025-10-062025-10-06$103M
Exact legal private partnership identified by current adviser FormADV, private-fund number 805-4009886936; GP CFG - ELEVANCE ONE GP, LLC. October6,2025 FormD reports offeringUSD103,763,908, soldsameamount, remaining0, firstsaleOctober2. Completed offering; named LP identities not inferred from fund name. Manager/fund and primary/secondary cash distinctions are preserved.
HEALTH CATALYST CAPITAL ANNEX FUND II, L.P.2024-12-062024-12-06$4M
Exact legal private partnership identified by current adviser FormADV, private-fund number 805-6740639015; GP HEALTH CATALYST ASSOCIATES ANNEX, LLC. December6,2024 FormD reports offeringUSD4M, soldUSD4M, remaining0; firstsaleNovember25,2024. Filing/publication date is not an inferred final closing day. Manager/fund and primary/secondary cash distinctions are preserved.
HEALTH CATALYST CAPITAL ANNEX FUND I, L.P.——
Exact legal private partnership identified by current adviser FormADV, private-fund number 805-5449330371; GP HEALTH CATALYST ASSOCIATES ANNEX, LLC. Current legal Annex FundI identification only. AUM/GAV is not fundraising cash; a complete close amount/day not established. Manager/fund and primary/secondary cash distinctions are preserved.
HEALTH CATALYST CAPITAL CONTINUATION FUND I, L.P.——
Exact legal private partnership identified by current adviser FormADV, private-fund number 805-2545062603; GP HEALTH CATALYST CAPITAL CONTINUATION FUND GP I, LLC. Initial2024 FormD reported0sold, firstsale not yet occurred and indefinite target. Current ADV GAV is not new capital; completed close unavailable. Manager/fund and primary/secondary cash distinctions are preserved.
HEALTH CATALYST CAPITAL II, L.P.——
Exact legal private partnership identified by current adviser FormADV, private-fund number 805-6669445125; GP HEALTH CATALYST ASSOCIATES II, LLC. May29,2020 amendment reports actual partialUSD50,752,500sold including GPcommitment, againstUSD275Mtarget; firstsaleJune25,2019. Final completed fundraising size unavailable; no target or GAV-as-close. Manager/fund and primary/secondary cash distinctions are preserved.
HEALTH CATALYST CAPITAL, L.P.——
Exact legal private partnership identified by current adviser FormADV, private-fund number 805-5362618866; GP HEALTH CATALYST ASSOCIATES, LLC. December2016 amendment reports partialUSD27,788,945sold againstUSD100Mtarget; additionalUSD37M expressly conditional and excluded. FirstsaleDecember14,2015. Final completed close size unavailable. Manager/fund and primary/secondary cash distinctions are preserved.